News | March 13, 2012

Tyrx Launched Patient Web Site on EP Device Infection

March 20, 2012 - TyRx Inc. announced the launch of its new patient education website, HeartDeviceInfection.com. It was created to raise awareness ofsurgical site infection associated with cardiac implantable electronic devices (CIEDs) including pacemakers and implantable defibrillators. It also offers information and resources for reducing that risk. It targets patients and caregivers.

“With CIED infections growing much faster than implantations, being very expensive to treat, and having a one-year mortality rate of about 30 percent, it is very important to widely and rapidly educate patients and caregivers that there is technology available that can help prevent these infections,” said TyRx Inc.

“With CIED infections growing much faster than implantations, being very expensive to treat, and having a one-year mortality rate of about 30 percent, it is very important to widely and rapidly educate patients and caregivers that there is technology available that can help prevent these infections," said Charles Kinder, M.D., director, heart rhythm program, Heart Care Centers of Illinois.

By launching HeartDeviceInfection.com, we are able to reach a very broad and diverse audience of patients and caregivers looking for information to address their heart health concerns. HeartDeviceInfection.com will serve as an important resource to help reduce the number of cardiac device infections impacting patients and the heath care system,” said TyRx CEO Robert White.

For more information: www.tyrx.com.

Related Content

HHS and NASA Team Up to Explore Health on Earth and in Outer Space

Image courtesy of NASA

News | EP Lab | December 14, 2018
The Department of Health and Human Services (HHS) recently entered into an interagency agreement with the National...
Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Myocarditis is an Under-recognized Etiology of Symptomatic Premature Ventricular Arrhythmia (PVCs). #HRS #HRS2018
News | EP Lab | May 18, 2018
May 18, 2018 — A significant number of patients with symptomatic premature ventricular contractions (PVCs) have under
Novel Antibiotics Can Help Lower EP Device Infection Rates. Pictured here is an ICD. Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

Implantation of pacemakers, ICDs and the related cardiac leads opens patients to infection risk.

News | EP Lab | May 17, 2018
May 10, 2018 – A new study is the first to test the clinical effectiveness of incremental peri-operative antibiotics
The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT). #HRS2018

The Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2 were all able to properly diagnose the very rapid heart beats involved in  paroxysmal supraventricular tachycardia (PSVT).  

News | EP Lab | May 16, 2018
May 16, 2018 — A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced
Overlay Init